Document ID: chunk:federal_register_of_legislation:F2024C00525:reg:5:p5
Version: federal_register_of_legislation:F2024C00525
Segment Type: reg
Provision Reference: reg 5 (pt 5/6)
Character Range: 27826–30493

to each person who holds any relevant position (whether in his or her own right or on someone else's behalf) in relation to the applicant's business that will undertake the activities:
 (i) the name and date of birth of the person;
 (ii) the position in the business held by the person;
 (h) details of the previous business experience of the directors and officers of the body corporate, and of the shareholders of the body corporate who are in a position to influence the management of the body corporate;
 (k) details of any matters that may affect whether the directors and officers of the body corporate are of good repute, being matters going to their character, honesty and professional and personal integrity;
 (l) the body corporate's history of compliance with the Act.

Additional information required if applicant proposes to manufacture a cannabis drug
 (5) If the applicant proposes to manufacture a cannabis drug, the application must also contain the following:
 (a) if the drug is to be supplied for use in a clinical trial that is, or is likely to be, approved under the Therapeutic Goods Act 1989 or notified to the Secretary under that Act—information about the clinical trial in which the drug is to be used;
 (b) if the drug is to be supplied in accordance with an approval or authority under that Act—information about that approval or authority;
 (c) if the drug is to be supplied to a person who holds a licence under Part 3‑3 of that Act for use by that person in the manufacture of a medicine (within the meaning of that Act)—information about the licence and the holder of the licence;
 (d) if the drug is registered goods within the meaning of that Act—the number assigned to the registered goods on the Australian Register of Therapeutic Goods maintained under section 9A of that Act;
 (e) if the drug is to be supplied to a pharmacist in a public hospital for the purposes of the pharmacist dispensing the drug in accordance with that Act—information about the hospital;
 (f) if the drug is to be supplied for use in medical or scientific research where that research is not a clinical trial referred to in paragraph (a) and does not involve the drug being administered to humans—information about the research including the name of the entity undertaking the research;
 (g) if the drug is to be supplied for use as a reference standard for medical or scientific testing purposes—information about the proposed use of the reference standard;
 (h) if the drug is to be supplied for export from Australia in accordance with a licence and permission under the Customs (Prohibited Exports) Regulations 1958—information about the licence and